Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

PURPOSE: Circulating tumor DNA (ctDNA) sequencing provides a minimally invasive method for tumor molecular stratification. Commercial ctDNA sequencing is increasingly used in the clinic, but its accuracy in metastatic prostate cancer is untested. We compared the commercial Guardant360 ctDNA test aga...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:JCO Precis Oncol
Hoofdauteurs: Taavitsainen, Sinja, Annala, Matti, Ledet, Elisa, Beja, Kevin, Miller, Patrick J., Moses, Marcus, Nykter, Matti, Chi, Kim N., Sartor, Oliver, Wyatt, Alexander W.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2019
Onderwerpen:
Original Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446428/
https://ncbi.nlm.nih.gov/pubmed/32914020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00014
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items